MK

Maruri Kumarswamy Reddy

Active Director Director DIN 09814740
DIN 09814740 First appointment Dec 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 10 active board seats
Total affiliations 10 Since Dec 2022
Shareholding value •••• Premium profile

About Maruri Kumarswamy Reddy

Data last updated:

Maruri Kumarswamy Reddy is a Director at Akron Formulations India Private Limited (since 2023), Director at Akron Parentarals Private Limited (since 2023) and Managing Director at Arha Pharmaceuticals Private Limited (since 2022), and holds 7 more current directorships. The companies operate in Pharma and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹78.54 Cr; the largest is Akron Formulations India Private Limited at ₹49.28 Cr (FY 2025).

DIN 09814740
Primary Designation Director
Industry Pharma
First Appointment 12 Dec 2022
Oldest Company Age 44 yrs
Largest company Akron Formulations India Private Limited · ₹49.28 Cr (FY 2025)
Combined revenue ₹78.54 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 20231985₹49.28 Cr (FY 2025)Active
Akron Parentarals Private Limited U24239AP1994PTC016773
Director22 May 20231994₹25.90 Cr (FY 2025)Active
Arha Pharmaceuticals Private Limited U24299TG2022PTC169136
Managing Director12 Dec 20222022₹3.21 Cr (FY 2026)Active
Akron Consumer Care Private Limited U24230AP1994PTC016927
Director22 May 20231994₹14.2 Lakh (FY 2025)Active
Aarna India Private Limited U21000AP2026PTC126707
Director03 Jul 20262026Active
Akron Beverages Private Limited U11040AP2026PTC124168
Director18 Feb 20262026Active
Akron Holdings Private Limited U64200AP2026PTC123962
Managing Director11 Feb 20262026Active
Aruri Labs Private Limited U72100TS2025PTC206660
Director24 Nov 20252025Active

Directorship timeline

Open interactive timeline →
Akron Consumer Care Private Limited
Arha Pharmaceuticals Private Limited
Aruri Labs Private Limited
Safe Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Maruri Kumarswamy Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maruri Kumarswamy Reddy

Maruri Kumarswamy Reddy currently holds 10 directorships: Akron Formulations India Private Limited (Director, since 27 Feb 2023, revenue ₹49.28 Cr (FY 2025)); Akron Parentarals Private Limited (Director, since 22 May 2023, revenue ₹25.90 Cr (FY 2025)); Arha Pharmaceuticals Private Limited (Managing Director, since 12 Dec 2022, revenue ₹3.21 Cr (FY 2026)); Akron Consumer Care Private Limited (Director, since 22 May 2023, revenue ₹14.2 Lakh (FY 2025)); Aarna India Private Limited (Director, since 03 Jul 2026); and 5 more.

Maruri Kumarswamy Reddy was first appointed on 12 Dec 2022 as Managing Director at Arha Pharmaceuticals Private Limited. The most recent appointment on record is 03 Jul 2026 at Aarna India Private Limited.

The 4 current companies of Maruri Kumarswamy Reddy that report revenue have a combined latest revenue of ₹78.54 Cr: Akron Formulations India Private Limited ₹49.28 Cr (FY 2025); Akron Parentarals Private Limited ₹25.90 Cr (FY 2025); Arha Pharmaceuticals Private Limited ₹3.21 Cr (FY 2026); Akron Consumer Care Private Limited ₹14.2 Lakh (FY 2025).

The current boards of Maruri Kumarswamy Reddy's companies include Kapil Mundhada (Akron Formulations India Private Limited), Maruri Leelavathi (Akron Formulations India Private Limited), Satyanarayana Reddy (Akron Formulations India Private Limited), Sivaramakrishnareddy Pathuri (Akron Parentarals Private Limited), Maruri Vijaya Bharath Reddy (Arha Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available